Literature DB >> 22094815

Charging of tRNAs using ribozymes and selection of cyclic peptides containing thioethers.

Patrick C Reid1, Yuki Goto, Takayuki Katoh, Hiroaki Suga.   

Abstract

In vitro selection methods represent a powerful approach toward identifying high-affinity peptide ligands from highly diverse peptide libraries against a desired target. We herein describe a method for the display and selection of cyclic thioether peptide libraries. Reprogramming the initiation event from fMet to an N-chloroacetyl-amino acid by utilizing flexizyme to rapidly and efficiently prepare the aa-tRNA can be effectively used to initiate translation, upon which the thiol group of an inserted cysteine at the C terminus of the designed library spontaneously reacts to yield a nonreducible cyclic thioether peptide readily compatible with any in vitro display methods. Thus, cyclic peptides already in a nonreducible stable form can be selected directly against the target of interest.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22094815     DOI: 10.1007/978-1-61779-379-0_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Synthesis of a large library of macrocyclic peptides containing multiple and diverse N-alkylated residues.

Authors:  Jumpei Morimoto; Thomas Kodadek
Journal:  Mol Biosyst       Date:  2015-10

2.  High-Throughput Quality Control Assay for the Solid-Phase Synthesis of DNA-Encoded Libraries of Macrocycles*.

Authors:  Animesh Roy; Eric Koesema; Thomas Kodadek
Journal:  Angew Chem Int Ed Engl       Date:  2021-04-13       Impact factor: 15.336

3.  Robust production of recombinant phosphoproteins using cell-free protein synthesis.

Authors:  Javin P Oza; Hans R Aerni; Natasha L Pirman; Karl W Barber; Charlotte M Ter Haar; Svetlana Rogulina; Matthew B Amrofell; Farren J Isaacs; Jesse Rinehart; Michael C Jewett
Journal:  Nat Commun       Date:  2015-09-09       Impact factor: 14.919

4.  Antibody-like proteins that capture and neutralize SARS-CoV-2.

Authors:  T Kondo; Y Iwatani; K Matsuoka; T Fujino; S Umemoto; Y Yokomaku; K Ishizaki; S Kito; T Sezaki; G Hayashi; H Murakami
Journal:  Sci Adv       Date:  2020-10-14       Impact factor: 14.136

5.  Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern.

Authors:  Taishi Kondo; Kazuhiro Matsuoka; Shun Umemoto; Tomoshige Fujino; Gosuke Hayashi; Yasumasa Iwatani; Hiroshi Murakami
Journal:  Life Sci Alliance       Date:  2022-03-07

Review 6.  Recent Advances Toward the Discovery of Drug-Like Peptides De novo.

Authors:  Michael Goldflam; Christopher G Ullman
Journal:  Front Chem       Date:  2015-12-18       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.